Literature DB >> 26040412

Subgingival bacterial community profiles in HIV-infected Brazilian adults with chronic periodontitis.

D C Ferreira1, L S Gonçalves1, J F Siqueira1, F L Carmo2, H F Santos2, M Feres3, L C Figueiredo3, G M Soares3, A S Rosado2, K R N dos Santos2, A P V Colombo2.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare the subgingival microbial diversity between non-HIV-infected and HIV-infected individuals with chronic periodontitis using denaturing gradient gel electrophoresis (DGGE).
MATERIAL AND METHODS: Thirty-two patients were selected: 11 were HIV-infected and 21 were non-HIV-infected, and all had chronic periodontitis. Periodontal measurements included probing depth, clinical attachment level, visible supragingival biofilm and bleeding on probing. Subgingival biofilm samples were collected from periodontal sites (50% with probing depth ≤ 4 mm and 50% with probing depth ≥ 5 mm) and whole-genomic-amplified DNA was obtained. The DNA samples were subjected to amplification of a 16S rRNA gene fragment using universal bacterial primers, followed by DGGE analysis of the amplified gene sequences.
RESULTS: The non-HIV-infected group presented higher mean full-mouth visible supragingival biofilm (p = 0.004), bleeding on probing (p = 0.006), probing depth (p < 0.001) and clinical attachment level (p = 0.001) in comparison with the HIV-infected group. DGGE analysis revealed 81 distinct bands from all 33 individuals. Banding profiles revealed a higher diversity of the bacterial communities in the subgingival biofilm of HIV-infected patients with chronic periodontitis. Moreover, cluster and principal component analyses demonstrated that the bacterial community profiles differed between these two conditions. High interindividual and intra-individual variability in banding profiles were observed for both groups.
CONCLUSION: HIV-infected patients with chronic periodontitis present greater subgingival microbial diversity. In addition, the bacterial communities associated with HIV-infected and non-HIV-infected individuals are different in structure.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV infections; bacterial community profiling; chronic periodontitis; denaturing gradient gel electrophoresis

Mesh:

Substances:

Year:  2015        PMID: 26040412     DOI: 10.1111/jre.12287

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  5 in total

1.  Evaluation of Association of Oral Bacterial Profile with HBV and HCV Infection and T Lymphocyte Level in HIV-Positive Patients.

Authors:  Fatemeh Lavaee; Farzan Modarresi; Samira Amookhteh; Mohammad Amin Amiri
Journal:  Int J Dent       Date:  2022-06-23

2.  Oral microbiome in HIV-associated periodontitis.

Authors:  Marc Noguera-Julian; Yolanda Guillén; Jessica Peterson; David Reznik; Erica V Harris; Sandeep J Joseph; Javier Rivera; Sunil Kannanganat; Rama Amara; Minh Ly Nguyen; Simon Mutembo; Roger Paredes; Timothy D Read; Vincent C Marconi
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

3.  Unique subgingival microbiota associated with periodontitis in cirrhosis patients.

Authors:  Anders Jensen; Lea Ladegaard Grønkjær; Palle Holmstrup; Hendrik Vilstrup; Mogens Kilian
Journal:  Sci Rep       Date:  2018-07-16       Impact factor: 4.379

4.  Significant effect of HIV/HAART on oral microbiota using multivariate analysis.

Authors:  Ann L Griffen; Zachary A Thompson; Clifford J Beall; Elizabeth A Lilly; Carolina Granada; Kelly D Treas; Kenneth R DuBois; Shahr B Hashmi; Chiranjit Mukherjee; Aubrey E Gilliland; Jose A Vazquez; Michael E Hagensee; Eugene J Leys; Paul L Fidel
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

5.  Stage II and stage III periodontitis clinical burdens of HIV-1 undergoing antiretroviral therapy.

Authors:  Lucio Souza Gonçalves; Dennis de Carvalho Ferreira; Fabio Vidal; Rodrigo Carvalho Souza; Cristiane Gonçalves; Priscila Pavan; Florence Carrouel; Denis Bourgeois; Gregory J Seymour
Journal:  Clin Oral Investig       Date:  2021-10-03       Impact factor: 3.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.